Exactus Stock Net Income
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Exactus' long-term financial health and intrinsic value.
Exactus |
Exactus OTC Stock Net Income Analysis
Exactus' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Exactus Net Income | (13.73 M) |
Most of Exactus' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exactus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Exactus reported net income of (13.73 Million). This is 104.02% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 102.4% higher than that of the company.
Exactus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exactus' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Exactus could also be used in its relative valuation, which is a method of valuing Exactus by comparing valuation metrics of similar companies.Exactus is currently under evaluation in net income category among its peers.
Exactus Fundamentals
| Return On Equity | -481.75 | |||
| Return On Asset | -137.67 | |||
| Current Valuation | 45.22 M | |||
| Shares Outstanding | 111.86 M | |||
| Shares Owned By Insiders | 30.01 % | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | (1.21) X | |||
| Price To Book | 3.99 X | |||
| Price To Sales | 6.34 X | |||
| Revenue | 1.24 M | |||
| Gross Profit | (3.13 M) | |||
| EBITDA | (8.83 M) | |||
| Net Income | (13.73 M) | |||
| Cash And Equivalents | 6.14 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 9.42 M | |||
| Debt To Equity | 0.78 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (560.82 K) | |||
| Earnings Per Share | (0.23) X | |||
| Beta | 4.32 | |||
| Market Capitalization | 8.17 M | |||
| Total Asset | 1.09 M | |||
| Retained Earnings | (21.69 M) | |||
| Working Capital | 833 K | |||
| Current Asset | 1.04 M | |||
| Current Liabilities | 206 K | |||
| Z Score | -52.0 |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. Note that the Exactus information on this page should be used as a complementary analysis to other Exactus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Exactus OTC Stock
If you are still planning to invest in Exactus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exactus' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |